• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE Back to Search Results
Model Number CREP G2
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/12/2023
Event Type  malfunction  
Manufacturer Narrative
Precision testing was performed with acceptable results.The field service engineer performed sample probe wash and air purge.The investigation is ongoing.(b)(4).
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with the crep2 (creatinine plus ver.2) assay on a cobas 6000 c 501 module, serial number (b)(4).The sample initially resulted in an invalid crep2 result, accompanied by a data flag.The sample was re-centrifuged and then repeated, resulting in a crep2 value of 0.92 mg/dl.This result was reported outside of the laboratory and questioned by the physician.The sample was repeated a second time, resulting in a crep2 value of 1.58 mg/dl.This result fits the clinical picture of the patient.
 
Manufacturer Narrative
A review of the initial data flag indicates that a sample clot was detected.The investigation could not identify a product problem.The cause of the event could not be determined.The issue is consistent with a sample quality-related issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16523478
MDR Text Key311079188
Report Number1823260-2023-00763
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public04015630919215
Combination Product (y/n)N
Reporter Country CodeTH
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Model NumberCREP G2
Device Catalogue Number03263991190
Device Lot Number663665
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/12/2023
Initial Date FDA Received03/10/2023
Supplement Dates Manufacturer Received03/13/2023
Supplement Dates FDA Received04/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-